Background: Acinetobacter baumannii is a Gram-negative opportunistic pathogen with a notorious reputation of being resistant to antimicrobial agents. The capability of A. baumannii to persist and disseminate between healthcare settings has raised a major concern worldwide. Methods: Our study investigated the antibiotic resistance features and molecular epidemiology of 52 clinical isolates of A. baumannii collected in Pakistan between 2013 and 2015. Antimicrobial susceptibility patterns were determined by the agar disc diffusion method. Comparative sequence analyses of the ampC and bla OXA-51-like alleles were used to assign the isolates into clusters. The whole genomes of 25 representative isolates were sequenced using the MiSeq Desktop Sequencer. Free online applications were used to determine the phylogeny of genomic sequences, retrieve the multilocus sequence types (ST), and detect acquired antimicrobial resistance genes.
Introduction
Acinetobacter baumannii is an important opportunistic pathogen that has increasingly been reported worldwide. The World Health Organization (WHO) has recently classified carbapenem resistant A. baumannii as a top priority organism for research and development of new antibiotics against antibiotic-resistant bacteria [1] . The
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Annals of Clinical Microbiology and Antimicrobials occurrence of A. baumannii in Pakistan was first reported in 2004, where it counted for 4.4% of the Gram-negative bacilli in a collection of 812 isolates obtained from a variety of clinical samples in Rawalpindi in 2002 [2] . Importantly, 72% of the reported A. baumannii isolates were found to be extended-spectrum beta-lactamase (ESBL) producers. Later, eight clusters of carbapenem-resistant isolates of A. baumannii were detected in two intensive care units in Karachi, Pakistan, between November 2007 and August 2008 [3] . Concurrently, A. baumannii was the most frequent bacterial pathogen among a collection of 50 carbapenem-resistant clinical isolates obtained in Rawalpindi in 2009 [4] . According to Kaleem et al., twenty-seven (84%) of the carbapenem-resistant A. baumannii isolates were metallo-beta-lactamase positive by the E-test strip method.
Recently, A. baumannii was isolated in 18% of patients with ventilator-associated pneumonia, making it the 4th most frequent pathogen, at the Khyber Teaching Hospital in Peshawar in 2013 [5] . Notably, A. baumannii was declared as the most resistant pathogen identified in this study. A. baumannii also ranked the second most commonly detected pathogen (24.7%) among a collection of carbapenemase producers obtained from one hospital in Lahore between 2015 and 2016 [6] . Furthermore, A. baumannii was the main isolated bacterium (39.8%) among a total of 113 isolates recovered from 80 ventilator-supported patients at the Foundation Hospital, Rawalpindi, in 2016 [7] .
Nevertheless, only few of these studies have plotted the epidemiology of A. baumannii in Pakistan onto a global map. Most of the 2007-2008 hospital-acquired carbapenem-resistant A. baumannii belonged to either International clone (IC) I or II [3] . Similarly, 1/17 and 7/17 clinical isolates of A. baumannii, obtained in 2008, were linked to ICs I and II, respectively [8] . Two isolates collected in Norway in 2009 with a history of import from Pakistan were assigned to sequence types 2 (ST2) and ST15, using the multilocus sequence typing (MLST) scheme of Pasteur Institute [9, 10] . ST2 is a key member of IC II while ST15 has often been reported in South America [11, 12] . Our search in the A. baumannii MLST databases yielded records of 4 isolates from Pakistan (last accessed in 11 September 2019). The 4 isolates were entered in 2019, which might explain why we could not find published literature on them. Two of these isolates belonged to ST1310 (8, 1, 5, 1, 6, 2, 3) or ST1327 (13, 1, 5, 26, 7, 1, 29) , for which there was no linkage to known ICs. The other two isolates belonged to ST1106 (2, 1, 2, 1, 5, 1, 1), a member of clonal complex CC1 corresponding to IC I [11] .
The aim of this study was to investigate the molecular epidemiology and antibiotic resistance features of 52 A. baumannii clinical isolates collected in Pakistan between 2013 and 2015. The clonality among our isolates was crossed over the global population of A. baumannii.
Materials and methods

Bacterial isolates
Two collections of A. baumannii clinical isolates were included in this study. The isolates, each recovered from one patient, were collected on a consecutive basis regardless of their antimicrobial susceptibility features ( Table 1 ). The first collection (n = 16) was obtained between February and September 2013 at the Combined Military Hospital in Lahore (CMH Lahore), while the second one (n = 36) was obtained between February and November 2015 at the Combined Military Hospital in Peshawar (CMH Peshawar). The geographic distance between the two hospitals is about 520 kilometres (Additional file 1: Figure S1 ). The isolates were cultured from pus (n = 17), respiratory secretions (n = 27), intravenous catheter tip (n = 5), Foley catheter tip (n = 2), and bile (n = 1). The clinical samples were processed according to standard in-house culture protocols. When needed, isolates were revived from frozen glycerol stocks onto Brain Heart Infusion agar plates or slants (Oxoid, Basingstoke, United Kingdom). Species identification was first determined using API 20 NE (BioMerieux, France) and later confirmed by detecting occurrence of the intrinsic bla OXA-51-like gene in all the isolates [13] . The identification was further verified by partial rpoB (zone 1, 352 bp) gene sequence analysis in 25 isolates selected for wholegenome sequencing [14] .
Antimicrobial susceptibility testing
Susceptibility of the isolates to ampicillin/sulbactam, piperacillin/tazobactam, cefepime, cefotaxime, ceftazidime, ceftriaxone, meropenem, imipenem, gentamicin, amikacin, tobramycin, ciprofloxacin, levofloxacin, trimethoprim/sulfamethoxazole, and minocycline was investigated by the agar disc diffusion method, using discs from Oxoid (Basingstoke, United Kingdom). The broth microdilution method was used for doxycycline (Pfizer Global pharmaceuticals), polymyxin B (Glaxosmith Kline pharmaceuticals), and colistin (Forest pharmaceuticals). The tests were performed and susceptibility patterns were interpreted following the guidelines of the Clinical and Laboratory Standards Institute (CLSI) [15] .
Strain typing
The isolates were typed using two single-locus molecular schemes based on the allelic identity of the A. baumannii-intrinsic ampC and bla OXA-51-like genes [16, 17] . PCR amplifications of ampC and bla OXA-51-like were performed using in-house designed primers (Additional Karah et al. Ann Clin Microbiol Antimicrob (2020) 19:2 file 2: Table S1) and followed by Sanger sequencing of the amplicons, as previously described [16, 17] . This approach was able to detect the occurrence of insertion sequence (IS) elements, such as ISAba1, in the bordering regions of ampC and/or bla OXA-51-like .
Whole-genome sequence analyses
Twenty-five isolates were selected for whole-genome sequencing based on their antimicrobial resistance patterns and strain typing results. Sequencing was performed using the MiSeq Desktop Sequencer and MiSeq Reagent Kit v3 (Illumina, San Diego, CA, USA). DNA preparation, library construction, and genome sequencing were done according to the manufacturers' instructions. Sequence data were assembled and analysed using the CLC genomics workbench (v7.0.4; CLC bio, Aarhus, Denmark). The web server Reference sequence Alignment-based Phylogeny builder (REALPHY) was used to construct a phylogenetic tree based on multiple alignments of the genomic sequence data [18] . Sequence reads were mapped to the genomes of three well-known reference strains: AYE (IC I, GenBank: NC_010410.1), ACICU (IC II, GenBank: NC_010611.1), and ATCC 17978 (sporadic ST437, GenBank: NZ_CP018664.1). An In-silico search was performed to detect the existence of 24 A. baumannii plasmid-borne replicase genes, according to the A. baumannii PCR-based replicon typing (AB-PBRT) scheme and a number of other studies on A. baumannii plasmids [19] [20] [21] [22] . The MLST web-based search engine, hosted by the Center for Genomic Epidemiology in Denmark (http://www.genom icepi demio logy. org/), was used to assign the isolates into STs according to the Institute Pasteur's MLST scheme (http://www. paste ur.fr/mlst) [23] . The occurrence of acquired antimicrobial resistance genes was detected using the Res-Finder service, also hosted by the Center for Genomic Epidemiology in Denmark [24] . The occurrence of resistance genes was verified, and genetic surroundings were annotated based on the yields of nucleotide similarities obtained using the Basic Local Alignment Search Tool (http://blast .ncbi.nlm.nih.gov/Blast .cgi) against the "Nucleotide collection (nr/nt)" and/or "Whole-genome shotgun contigs (wgs)" databases [25] . The presence of neighbouring IS elements was detected using the ISfinder online application [26] .
Nucleotide sequence accession numbers
Draft genome sequences of all the isolates were deposited in the DDBJ/EMBL/GenBank database under the BioProject accession number: PRJNA482499. The versions described in this paper are QQPR01000000, SMUA01000000, QQPS01000000, QQPT01000000, SMUB01000000, SMUC01000000, SMUD01000000, QQPU01000000, QQPV01000000, QQPW01000000, SMUE01000000, SMUF01000000, SMUG01000000, SMUQ01000000, QQPX01000000, SMUR01000000, QQPY01000000, SMUH01000000, SMUI01000000, QQPZ01000000, SMUJ01000000, QQQA01000000, QQQB01000000, SMUK01000000, and QQQC01000000. The new alleles ampC-78 and ampC-79 were deposited in the ampC database hosted at the A. baumannii MLST website (http://pubml st.org/abaum annii /) and in the DDBJ/EMBL/GenBank database under the accession numbers MK634301.1 (bla ) and MK690541.1 (bla ADC-91 ), respectively.
Results and discussion
Antimicrobial resistance patterns
The isolates showed resistance rates of 100% (52/52) to ampicillin/sulbactam, piperacillin/tazobactam, cefepime, cefotaxime, ceftazidime, ceftriaxone, meropenem, gentamicin, tobramycin, ciprofloxacin, levofloxacin, and trimethoprim/sulfamethoxazole (Table 1 and Additional  file 3: Table S2 ). In addition, 98.1% (51/52) of the isolates were resistant to amikacin and imipenem, 32.7% (17/52) to minocycline, 30.8% (16/52) to doxycycline, and 0% (0/52) to colistin and polymyxin B ( Table 1 and Additional file 3: Table S2 ). All the isolates were resistant to ≥ 3 classes of antibiotics and were accordingly defined as multidrug-resistant [27] . The results were in line with previous studies describing extensive occurrence of multidrug-resistant strains of A. baumannii in Pakistan [28] [29] [30] . However, our results could be partially biased by the predominance of few genetically related clusters of isolates, as described in the next paragraph.
Strain typing
Comparative sequence analysis of the bla OXA-51-like and ampC loci enabled us to group 49/52 of the isolates into seven clusters, designated Ab-Pak-cluster-1 to -7 ( Table 2 ). The remaining 3 isolates (Ab-Pak-Lah-01, Ab-Pak-Pesh-04 and Ab-Pak-Pesh-22) were considered as individual strains. Ab-Pak-cluster-1 (bla OXA-66 , ISAba1-ampC-19) was the largest cluster with 24 isolates distributing between Lahore, 2013 (n = 14) and Peshawar, 2015 (n = 10). The second largest cluster, Ab-Pak-cluster-2 (bla OXA-66 , ISAba1-ampC-2), included 7 isolates, which were all detected in Peshawar, 2015. Ab-Pak-cluster-3 (bla OXA-66 , ISAba1-ampC-20) included 4 isolates and was also exclusive to Peshawar, 2015. Individual strain Ab-Pak-Lah-01 (ISAba1-bla OXA-66 , ISAba1-ampC-2) was the only isolate in our collection carrying insertion sequence ISAba1 upstream its intrinsic bla OXA-51-like gene ( Table 2 ). Based on their bla OXA-51-like and ampC alleles, Ab-Pak-clusters-1, -2 and -3, and individual strain Ab-Pak-Lah-01 belonged to A. baumannii IC II [11, 16, 17] .
Ab-Pak-cluster-4 (bla OXA-69 , ampC-1) and Ab-Pakcluster-5 (bla OXA-69 , ISAba1-ampC-78) included 3 and 2 isolates, respectively, and were both collected in Peshawar, 2015. The ampC-78 allele had a novel sequence according to the nucleotide database of ampC alleles in A. baumannii (https ://pubml st.org/abaum annii /). Ab-Pak-cluster-6 (bla OXA-371 ) included 4 isolates scattering between Lahore, 2013 (1 isolate) and Peshawar, 2015 (3 isolates). The 4 isolates were equally divided into two sub-clusters, namely Ab-Pak-sub-cluster-6A (bla OXA-371 , ISAba1-ampC-3) and -6B (bla OXA-371 , ISAba1-ampC-8).
The nucleotide identity of ampC-8 (1167 bp) is 100% identical to ampC-3 (1152 bp) apart from having a duplicated segment of 15 nucleotides (Additional file 4: File S1). The bla OXA-371 allele was only one nucleotide different in comparison to bla OXA-69 (GenBank accession numbers NG_049662.1 and NG_049809.1). Ab-Pak-clusters-4, -5, -6A, and -6B could conceivably be classified under the umbrella of IC I [16, 17, 31] . Ab-Pak-cluster-7 (bla OXA-65 , ampC-43) included 5 isolates that were collected in Peshawar, 2015. The bla OXA-65 allele in Ab-Pak-cluster-7 encoded for ß-lactamase OXA-65 (GenBank: WP_001021782.1). However, this allele had 3 synonymous nucleotide substitutions in comparison to the first GenBank-deposited allele for OXA-65 (Gen-Bank: NG_049805.1). This deviation revealed an inherent shortage in the current numbering system of the bla OXA genes [32, 33] . In this regard, we would restate our view that alleles of well-defined bacterial genes should be numbered based on their nucleotide identifies rather than their amino acid sequences [16] . Lastly, the individual strains Ab-Pak-Pesh-04 (bla OXA-64 , ampC- 25) and Ab-Pak-Pesh-22 (bla OXA-68 , ISAba1-ampC-79) were assigned into CC25 and CC23, respectively [34, 35] .
Whole-genome phylogenetic tree
Among the 25/52 isolates selected for whole genome sequence analysis, Ab-Pak-clusters-1, -2, -3, -4, -5, -6A, -6B, -7 were represented by 6 (showing 3 different antimicrobial resistance patterns)/24, 3/7, 2/4, 2/3, 2/2, 2/2, 2/2, and 3/5 isolates, respectively. The three individual isolates were also included. The genome assembly features were presented in Additional file 5: Table S3 . The whole-genome phylogenetic tree showed a branching pattern indorsing the assembly of Ab-Pak-cludters-2, -3, -4, -5 and -7 (Fig. 1) . The distinction between Ab-Pak-cludters-6A and -6B was also confirmed. The six isolates of Ab-Pak-cluster-1 were distributed on two detached branches and a few sub-branches. Such a high discriminatory power of whole-genome phylogenetic analyses, compared to loci-focused strain typing approaches, has been noted in previous studies [36, 37] . Nevertheless, the internal splits in Ab-Pak-cluster-1 were most likely related to a long-standing presence of this cluster. In addition, the tree showed a noticeably well-demarcated positioning of Ab-Pak-cluster-7 far from ICs I and II. Sequencing the whole genome of more isolates, especially from Ab-Pak-cluster-1, would have increased our capacity to confirm or exclude transmission events between patients [38] . However, such a limitation is generally tolerable when resources are limited.
Plasmid replicase genes
The isolates carried between 1 and 4 plasmid replicase genes (Additional file 6: Table S4 ). The most commonly detected genes were repAci6 (16/25) and repAci1/repAci2 (15/25) , which was in line with earlier studies elsewhere [39] . Interestingly, repAci9 was detected in 12/25 of the isolates. The repAci9positive plasmids ranged in size between 10,000 and 16,000 base pairs (bp), similarly to what has commonly been described (GenBank accession numbers: LT594096.1, CP024577.1, CP040088.1, CP035673.1, and AY541809.1). However, the individual isolate Ab-Pak-Pesh-22 carried a relatively large repAci9-positive plasmid, with the size of 31,442 bp (GenBank: SMUR01000022.1), on which the tet(39) tetracycline resistance operon was detected.
Other replicase genes, such as repAci4 and the replicase genes of p2ABSDF and p4AYE, were present in 2/25, 5/25, and 4/25 of the isolates, respectively. Two isolates, Ab-Pak-Pesh-20 and Ab-Pak-Pesh-27, from Ab-Pak-cluster-4 carried a replicase gene with novel nucleotide identity, designated repAci24, showing only 58% nucleotide identity to the replicase gene of p3ABSDF (GenBank: CU468233.1). The three Ab-Pakcluster-7 isolates carried another novel replicase gene, designated repAci25, which will be further discussed below. The occurrence of partial sequences of some replicase genes was noted in the genomes of few isolates (Additional file 6: Table S4 ). Our in silico analysis was not able to confirm or exclude if these incomplete sequences represented or belonged to actual plasmids. or Tn2008 (12 isolates). Some isolates, such as Ab-Pak-Lah-04 and Ab-Pak-Lah-08 from Ab-Pak-cluster-1, carried three copies of bla OXA-23 . Of note, only one copy was intact while the other two were truncated at their 5′ extremities (data not published). A similar scenario was detected in strain AbPK1 (GenBank: CP024576). Interestingly, AbPK1 was collected in Pakistan in 2012. It also belonged to ST2 and had the ampC-19 and bla OXA-66 alleles [47] . Although it was isolated from infected animals, AbPK1 had a strong genotypic linkage to Ab-Pak-cluster-1.
The individual strain Ab-Pak-Pesh-22 was resistant to meropenem but susceptible to imipenem. Interestingly, Ab-Pak-Pesh-22 did not carry bla or any other commonly known mechanism for carbapenem resistance. On the other hand, Ab-Pak-Lah-01 was equipped with two mechanisms conferring carbapenem resistance, an acquired bla OXA-23 gene and an intrinsic bla OXA-66 gene proceeded by ISAba1 [48] . None of our isolates carried the class D ß-lactamase bla OXA-24-like or bla OXA-58-like genes.
Overall, our results were in line with previous studies nominating OXA-23 as the most commonly detected group of acquired Class D β-lactamases in A. baumannii both in the region and throughout the world [49] [50] [51] . The occurrence of ISAba1 upstream of bla OXA-23 , bla OXA-66 , ampC-2, ampC -3, ampC-8, ampC-19, ampC-20, ampC-78, or ampC-79 has the potential to overexpress these genes, which might subsequently confer resistance to carbapenems (bla OXA ) or ceftazidime (ampC) as previously proposed [48, 52, 53] .
Class A extended-spectrum ß-lactamase genes were detected in 14/25 of the isolates, among which bla PER-1 , bla TEM-1D , bla and bla PER-7 were carried by 5, 5, 3, and 1 isolate, respectively. There was no co-existence of more than one class A ß-lactamase gene per isolate. All the isolates (25/25) carried aminoglycoside resistance genes. Each isolate carried between 2 to 7 aminoglycoside resistance genes. The occurrence rates ranged from 20/25 for aphA6a and strB, 16/25 for strA, 13/25 for aacC1, 8/25 for aphA1b, 7/25 for aadA1, 4/25 for aphA6b, aadB, and aacA4, and 1/25 for aacC2. The 16S rRNA methylase armA gene, commonly conferring high levels of resistance to aminoglycosides [54] , was detected in 3 isolates, namely Ab-Pak-Pesh-04, Ab-Pak-Pesh-31, and Ab-Pak-Pesh-36. The inhibition zone diameters of gentamicin 10 μg, amikacin 30 μg, and tobramycin 10 μg for these armA-positive isolates did not show a unique resistance pattern compared to the armA-negative isolates (Additional file 3: Table S2 ).
The macrolide resistance 2′-phophotransferase msr(E)mph(E) operon was present in 15/25 isolates. The sulphonamide resistance genes sul2 and sul1 were detected in 14/25 and 11/25 isolates, respectively, with 3 isolates having both sul2 and sul1. The tetracycline resistance genes tet(B), tet(A), and tet (39) were detected in 9/25, 2/25, and 1/25 isolates, respectively, with no cases of overlapping. Other resistance genes, such as floR, catA1, cmlA5, and catB8 (chloramphenicol resistance), dfrA7 and dfrA1 (trimethoprim resistance), and arr-2 (rifampicin resistance) had low rates of occurrence ranging between 1/24 and 4/24 (Additional file 7: Table S5 ). 
Antimicrobial resistance features of Ab-Pak-cluster-7
Ab-Pak-cluster-7 was equipped with 8 acquired antimicrobial resistance genes, namely: bla OXA-23 , bla GES-11 , aphA6a, aacA4, sul1, drfA7, msr(E) and mph(E). The bla OXA-23 gene was located on transposon Tn2008 with genetic surroundings identical to plasmid pK50a carried by isolate K50 [41] . Four genes, aacA4, drfA7, bla and sul1, were part of a truncated class one integron (Fig. 2) . The integron was bounded by two miniature inverted-repeat transposable elements (MITE), forming a mobile element of 7486 bp. The insertion of this mobile element created a characteristic target site duplication of 5-bp [55] . The same element was previously found on plasmids pK50a [41] , p1AB5075 (CP008707.1), and pAb8098 (KY022424.1). It was also detected in the whole genome sequence of isolates 428 (MDTS01000040.1) and IS-251 (AMEJ01000018.1). The aphA6a gene in Ab-Pakcluster-7 was located on transposon TnaphA6, inserted at the same location as previously described for plasmids pAb-G7-2 (KF669606.1) and pAbPK1b (CP024578.1). Of note, TnaphA6 was missing in isolate K50.
The msr(E)-mph(E) macrolide resistance operon in Ab-Pak-cluster-7 was surrounded by two pdif sites creating a module with a probable movability mediated by the XerC-XerD system [56] . The msr(E)-mph(E) operon was co-located on a contig carrying the repAci25 gene, encoding for novel plasmid replication initiator protein from the Rep_3 protein family (pfam01051) and superfamily (cl19398). repAci25 had a nucleotide identity of 91% to repAci4 (GenBank: GU978998.1). A close allele to repAci25, with 99.6% nucleotide identity, was detected on plasmids p597A-14.8 (GenBank: CP033871.1), pAb825_36 (GenBank: MG100202.1), pAb244_7 (GenBank: MG520098.1), and pAb242_9 (GenBank: KY984045.1). Among other Acinetobacter species, repAci25 was detected in the whole genome sequence of Acinetobacter bereziniae (100% nucleotide identity, GenBank: CDEL01000266.1) and Acinetobacter radioresistens (99.7% nucleotide identity, GenBank: PXJE01000090.1). Interestingly, plasmid pALWVS1.1 in Acinetobacter lwoffii strain VS15 had a gene showing 96.7% nucleotide identity to repAci25 (GenBank: KX426232.1). The age of the permafrost sediment, from which VS15 was obtained, was estimated to be around 2 to 3 million years [57] .
Conclusion
Our study demonstrated that uncomplicated sequence typing schemes, based on comparative analysis of one or two intrinsic loci, such as ampC and bla OXA-51-like , could be a practical approach for rapid grouping of bacterial clinical isolates, such as A. baumannii. However, further validation of the results is commonly needed. The occurrence of a 100% rate of multidrug-resistant strains is alarming and worth a rapid action plan, including regular follow ups and urgent management procedures. The study enabled us to detect seven clusters of A. baumannii prevailing in two clinical settings in Pakistan. Two of these clusters, Ab-Pak-cluster-1 and -6, lasted for more than 2 years and were able to spread between Lahore and Peshawar. The predominance of IC II in Pakistan was in line with the intensive circulation of this clone worldwide (11) . The frequent occurrence of isolates belonging to IC I underlined that this clone is still a key trouble-maker in several parts of the world, including Pakistan. Significantly, Pakistan and the Middle East could be a reservoir for under-detected clones of carbapenem-resistant A. baumannii, including the bla OXA-23 -and bla GES-11 -positive ST158. The clinical significance and virulence features of ST158, represented by Ab-Pak-cluster-7 in Pakistan, is worth further investigations.
